Wednesday, January 3, 2024

🌎 BorgWarner Downgraded, LyondellBasell Industries Upgraded, Aurora Innovation Downgraded and more...

Ratings changes for SoFi Technologies, Streamline Health Solutions, CME Group, Aurora Innovation, Green Plains Partners, Logitech International, Omnicell and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
Unsubscribe.
MarketBeat Daily Ratings
January 3rd, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 

Today's Top Stories
5 crypto stocks to watch amidst Bitcoin's ascendance
Two large offshore wind sites are sending power to the US grid for the first time
Public Service Announcement: New National Emergency Incoming (Porter and Company)
UniFirst stock falls into the buy zone
US job openings fell slightly in November but remain high by historical standards
5 Reasons Under Armour stock may not trade under $10 for long
Disney inks agreement with ValueAct, secures its support for company's board nominees
Buy THIS stock before Taiwan is attacked (Behind the Markets)
4 takeaways from the first day of trading in 2024
Edmunds recommends the best vehicles for achieving your New Year's resolutions
Intel stock: Analysts are expecting multi-year highs
EU targets world's biggest diamond miner as part of Russia war sanctions
3 Fitness Stocks Ready to Rally
Quick Links

Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Ameriprise Financial (NYSE:AMP) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $452.00 price target on the stock, up previously from $355.00. This represents a 17.9% upside from the current price of $383.42.
  • AptarGroup (NYSE:ATR) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $150.00 price target on the stock, up previously from $125.00. This represents a 18.8% upside from the current price of $126.27.
  • BCE (NYSE:BCE) (TSE:BCE) was upgraded by analysts at TD Securities from a "hold" rating to a "buy" rating.The current price is $40.65.
  • Citigroup (NYSE:C) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $58.00 price target on the stock. This represents a 8.8% upside from the current price of $53.33.
  • Civitas Resources (NYSE:CIVI) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $86.00 price target on the stock, down previously from $96.00. This represents a 26.3% upside from the current price of $68.08.
  • CNX Resources (NYSE:CNX) was upgraded by analysts at Mizuho from an "underperform" rating to a "neutral" rating.The current price is $20.57.
  • Discover Financial Services (NYSE:DFS) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $129.00 price target on the stock, up previously from $104.00. This represents a 16.3% upside from the current price of $110.96.
  • Gaotu Techedu (NYSE:GOTU) was upgraded by analysts at Citigroup Inc. from a "sell" rating to a "buy" rating. They now have a $4.50 price target on the stock, up previously from $2.48. This represents a 20.3% upside from the current price of $3.74.
  • GSK (NYSE:GSK) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating.The current price is $38.39.
  • Huntington Bancshares (NASDAQ:HBAN) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $15.00 price target on the stock, up previously from $10.50. This represents a 18.8% upside from the current price of $12.63.
  • Health Catalyst (NASDAQ:HCAT) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $11.00 price target on the stock, up previously from $9.00. This represents a 16.5% upside from the current price of $9.44.
  • Infosys (NYSE:INFY) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.The current price is $17.84.
  • Jumia Technologies (NYSE:JMIA) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $3.60 price target on the stock, up previously from $3.00. This represents a 1.6% downside from the current price of $3.66.
  • Lazard (NYSE:LAZ) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $42.00 price target on the stock. This represents a 14.2% upside from the current price of $36.79.
  • LyondellBasell Industries (NYSE:LYB) was upgraded by analysts at Vertical Research from a "hold" rating to a "buy" rating.The current price is $95.96.
  • New York Community Bancorp (NYSE:NYCB) was upgraded by analysts at Wedbush from an "underperform" rating to a "neutral" rating. They now have a $8.00 price target on the stock. This represents a 21.9% downside from the current price of $10.24.
  • PBF Energy (NYSE:PBF) was upgraded by analysts at Mizuho from a "neutral" rating to a "buy" rating. They now have a $52.00 price target on the stock. This represents a 19.4% upside from the current price of $43.56.
  • PNM Resources (NYSE:PNM) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $44.00 price target on the stock. This represents a 11.5% upside from the current price of $39.47.
  • PPG Industries (NYSE:PPG) was upgraded by analysts at Vertical Research from a "hold" rating to a "buy" rating.The current price is $144.96.
  • Pactiv Evergreen (NASDAQ:PTVE) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $16.00 price target on the stock, up previously from $10.00. This represents a 13.0% upside from the current price of $14.16.
  • Rockwell Automation (NYSE:ROK) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $360.00 price target on the stock, up previously from $305.00. This represents a 17.4% upside from the current price of $306.65.
  • Southern First Bancshares (NASDAQ:SFST) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $44.00 price target on the stock, up previously from $34.00. This represents a 15.8% upside from the current price of $38.00.
  • State Street (NYSE:STT) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $92.00 price target on the stock, up previously from $69.00. This represents a 18.7% upside from the current price of $77.52.
  • Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by analysts at Piper Sandler from an "underweight" rating to a "neutral" rating. They now have a $12.00 price target on the stock, up previously from $8.00. This represents a 9.4% upside from the current price of $10.97.
  • Unum Group (NYSE:UNM) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $55.00 price target on the stock. This represents a 19.0% upside from the current price of $46.23.
  • Verizon Communications (NYSE:VZ) was upgraded by analysts at KeyCorp from a "sector weight" rating to an "overweight" rating. They now have a $45.00 price target on the stock. This represents a 14.4% upside from the current price of $39.33.
  • Yum! Brands (NYSE:YUM) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $146.00 price target on the stock, up previously from $126.00. This represents a 12.7% upside from the current price of $129.52.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Ambarella (NASDAQ:AMBA) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $65.00 price target on the stock, down previously from $85.00. This represents a 14.7% upside from the current price of $56.66.
  • Aptiv (NYSE:APTV) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $96.00 price target on the stock, down previously from $105.00. This represents a 12.4% upside from the current price of $85.38.
  • Antero Resources (NYSE:AR) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $27.00 price target on the stock. This represents a 18.2% upside from the current price of $22.84.
  • Aurora Innovation (NASDAQ:AUR) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $2.00 price target on the stock, up previously from $1.75. This represents a 41.9% downside from the current price of $3.44.
  • Avery Dennison (NYSE:AVY) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $214.00 price target on the stock, up previously from $197.00. This represents a 8.1% upside from the current price of $198.04.
  • AstraZeneca (NASDAQ:AZN) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating.The current price is $67.94.
  • Bread Financial (NYSE:BFH) was downgraded by analysts at Evercore ISI from an "in-line" rating to an "underperform" rating. They now have a $33.00 price target on the stock, up previously from $29.00. This represents a 2.7% upside from the current price of $32.13.
  • Bristol-Myers Squibb (NYSE:BMY) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $60.00 price target on the stock, down previously from $68.00. This represents a 15.3% upside from the current price of $52.06.
  • BellRing Brands (NYSE:BRBR) was downgraded by analysts at Truist Financial Co. from a "buy" rating to a "hold" rating. They now have a $50.00 price target on the stock, down previously from $55.00. This represents a 4.3% downside from the current price of $52.25.
  • BorgWarner (NYSE:BWA) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $39.00 price target on the stock, down previously from $45.00. This represents a 14.3% upside from the current price of $34.13.
  • Blackstone (NYSE:BX) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $128.00 price target on the stock, up previously from $115.00. This represents a 4.3% upside from the current price of $122.68.
  • CACI International (NYSE:CACI) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $350.00 price target on the stock, down previously from $375.00. This represents a 10.5% upside from the current price of $316.67.
  • CBRE Group (NYSE:CBRE) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "in-line" rating. They now have a $96.00 price target on the stock, up previously from $79.00. This represents a 7.2% upside from the current price of $89.57.
  • Cullen/Frost Bankers (NYSE:CFR) was downgraded by analysts at Evercore ISI from an "in-line" rating to an "underperform" rating. They now have a $111.00 price target on the stock, up previously from $98.00. This represents a 3.9% upside from the current price of $106.86.
  • Chesapeake Energy (NASDAQ:CHK) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $96.00 price target on the stock. This represents a 24.9% upside from the current price of $76.86.
  • CME Group (NASDAQ:CME) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $195.00 price target on the stock. This represents a 3.9% downside from the current price of $202.97.
  • Callon Petroleum (NYSE:CPE) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $40.00 price target on the stock, down previously from $60.00. This represents a 21.4% upside from the current price of $32.94.
  • Crescent Energy (NYSE:CRGY) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $14.00 price target on the stock, down previously from $18.00. This represents a 10.8% upside from the current price of $12.63.
  • Comstock Resources (NYSE:CRK) was downgraded by analysts at Mizuho from a "neutral" rating to an "underperform" rating.The current price is $8.84.
  • Equitable (NYSE:EQH) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $36.00 price target on the stock, up previously from $35.00. This represents a 11.0% upside from the current price of $32.44.
  • Gulfport Energy (NASDAQ:GPOR) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $148.00 price target on the stock. This represents a 10.4% upside from the current price of $134.09.
  • Keurig Dr Pepper (NASDAQ:KDP) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $37.00 price target on the stock. This represents a 13.3% upside from the current price of $32.65.
  • Kymera Therapeutics (NASDAQ:KYMR) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $30.00 price target on the stock, down previously from $45.00. This represents a 26.2% upside from the current price of $23.77.
  • LianBio (NASDAQ:LIAN) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating. They now have a $3.00 price target on the stock, down previously from $5.00. This represents a 29.4% downside from the current price of $4.25.
  • Lincoln National (NYSE:LNC) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $26.00 price target on the stock. This represents a 1.5% downside from the current price of $26.40.
  • Masimo (NASDAQ:MASI) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.The current price is $110.22.
  • Magna International (NYSE:MGA) (TSE:MG) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $58.00 price target on the stock, down previously from $73.00. This represents a 3.9% upside from the current price of $55.84.
  • Maximus (NYSE:MMS) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $78.52.
  • Mercury Systems (NASDAQ:MRCY) was downgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to an "underperform" rating. They now have a $30.00 price target on the stock, down previously from $35.00. This represents a 9.5% downside from the current price of $33.15.
  • MaxLinear (NYSE:MXL) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $25.00 price target on the stock, down previously from $35.00. This represents a 15.5% upside from the current price of $21.64.
  • Northern Trust (NASDAQ:NTRS) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating. They now have a $85.00 price target on the stock. This represents a 2.5% upside from the current price of $82.91.
  • O-I Glass (NYSE:OI) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $18.00 price target on the stock, up previously from $17.00. This represents a 16.3% upside from the current price of $15.48.
  • Occidental Petroleum (NYSE:OXY) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $63.00 price target on the stock. This represents a 4.4% upside from the current price of $60.34.
  • PureCycle Technologies (NYSE:PCT) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating. They now have a $4.00 price target on the stock. This represents a 11.7% upside from the current price of $3.58.
  • PNM Resources (NYSE:PNM) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $41.00 price target on the stock. This represents a 3.9% upside from the current price of $39.47.
  • Silgan (NYSE:SLGN) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $47.00 price target on the stock, up previously from $44.00. This represents a 6.6% upside from the current price of $44.09.
  • Southwestern Energy (NYSE:SWN) was downgraded by analysts at Mizuho from a "neutral" rating to an "underperform" rating. They now have a $6.00 price target on the stock, down previously from $9.00. This represents a 7.7% downside from the current price of $6.50.
  • Wendy's (NASDAQ:WEN) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $21.00 price target on the stock, down previously from $23.00. This represents a 10.4% upside from the current price of $19.03.
  • Exxon Mobil (NYSE:XOM) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $117.00 price target on the stock. This represents a 13.8% upside from the current price of $102.81.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Apple (NASDAQ:AAPL) is now covered by analysts at DA Davidson. They set a "neutral" rating and a $166.00 price target on the stock. This represents a 9.8% downside from the current price of $184.06.
  • Accolade (NASDAQ:ACCD) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $13.00 price target on the stock. This represents a 14.0% upside from the current price of $11.40.
  • Amylyx Pharmaceuticals (NASDAQ:AMLX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $37.00 price target on the stock. This represents a 135.8% upside from the current price of $15.69.
  • Cardinal Health (NYSE:CAH) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $117.00 price target on the stock. This represents a 13.3% upside from the current price of $103.30.
  • Cencora (NYSE:COR) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $242.00 price target on the stock. This represents a 15.1% upside from the current price of $210.33.
  • Computer Programs and Systems (NASDAQ:CPSI) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $12.00 price target on the stock. This represents a 13.9% upside from the current price of $10.54.
  • Quest Diagnostics (NYSE:DGX) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $145.00 price target on the stock. This represents a 3.1% upside from the current price of $140.60.
  • Doximity (NASDAQ:DOCS) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $31.00 price target on the stock. This represents a 12.0% upside from the current price of $27.69.
  • Consolidated Edison (NYSE:ED) is now covered by analysts at LADENBURG THALM/SH SH. They set a "neutral" rating and a $92.50 price target on the stock. This represents a 0.0% downside from the current price of $92.54.
  • Enovis (NYSE:ENOV) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $55.21.
  • Evolent Health (NYSE:EVH) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $39.00 price target on the stock. This represents a 21.3% upside from the current price of $32.15.
  • Health Catalyst (NASDAQ:HCAT) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $14.00 price target on the stock. This represents a 48.3% upside from the current price of $9.44.
  • HealthEquity (NASDAQ:HQY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $84.00 price target on the stock. This represents a 23.7% upside from the current price of $67.88.
  • HealthStream (NASDAQ:HSTM) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $32.00 price target on the stock. This represents a 18.9% upside from the current price of $26.91.
  • Intra-Cellular Therapies (NASDAQ:ITCI) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $83.00 price target on the stock. This represents a 18.4% upside from the current price of $70.08.
  • Jazz Pharmaceuticals (NASDAQ:JAZZ) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $160.00 price target on the stock. This represents a 25.4% upside from the current price of $127.56.
  • LifeStance Health Group (NASDAQ:LFST) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $7.00 price target on the stock. This represents a 5.0% downside from the current price of $7.37.
  • Laboratory Co. of America (NYSE:LH) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $222.00 price target on the stock. This represents a 3.3% downside from the current price of $229.49.
  • Li Auto (NASDAQ:LI) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.The current price is $35.28.
  • McKesson (NYSE:MCK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $537.00 price target on the stock. This represents a 11.7% upside from the current price of $480.56.
  • Veradigm (NASDAQ:MDRX) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $11.00 price target on the stock. This represents a 2.1% upside from the current price of $10.77.
  • NIO (NYSE:NIO) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating on the stock.The current price is $8.35.
  • NVIDIA (NASDAQ:NVDA) is now covered by analysts at DA Davidson. They set a "neutral" rating and a $410.00 price target on the stock. This represents a 14.4% downside from the current price of $478.81.
  • Omnicell (NASDAQ:OMCL) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $33.00 price target on the stock. This represents a 5.9% downside from the current price of $35.06.
  • Owens & Minor (NYSE:OMI) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $21.00 price target on the stock. This represents a 10.2% upside from the current price of $19.06.
  • OptimizeRx (NASDAQ:OPRX) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $15.00 price target on the stock. This represents a 8.0% upside from the current price of $13.89.
  • Progyny (NASDAQ:PGNY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $48.00 price target on the stock. This represents a 30.5% upside from the current price of $36.77.
  • Phreesia (NYSE:PHR) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $29.00 price target on the stock. This represents a 30.0% upside from the current price of $22.31.
  • Premier (NASDAQ:PINC) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $22.00 price target on the stock. This represents a 1.2% downside from the current price of $22.27.
  • R1 RCM (NASDAQ:RCM) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $14.00 price target on the stock. This represents a 37.7% upside from the current price of $10.17.
  • 374Water (NASDAQ:SCWO) is now covered by analysts at Maxim Group. They set a "buy" rating and a $3.00 price target on the stock. This represents a 113.1% upside from the current price of $1.41.
  • Silk Road Medical (NASDAQ:SILK) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $20.00 price target on the stock. This represents a 69.8% upside from the current price of $11.78.
  • Sempra (NYSE:SRE) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $81.50 price target on the stock. This represents a 7.5% upside from the current price of $75.84.
  • Talkspace (NASDAQ:TALK) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $2.50 price target on the stock. This represents a 9.2% upside from the current price of $2.29.
  • Teladoc Health (NYSE:TDOC) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $26.00 price target on the stock. This represents a 23.0% upside from the current price of $21.13.
  • Utz Brands (NYSE:UTZ) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $20.00 price target on the stock. This represents a 15.9% upside from the current price of $17.26.
  • VinFast Auto (NASDAQ:VFS) is now covered by analysts at BTIG Research. They set a "buy" rating and a $10.00 price target on the stock. This represents a 43.5% upside from the current price of $6.97.
  • Walgreens Boots Alliance (NASDAQ:WBA) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $21.00 price target on the stock. This represents a 18.1% downside from the current price of $25.64.
  • Windtree Therapeutics (NASDAQ:WINT) is now covered by analysts at HC Wainwright. They set a "neutral" rating on the stock.The current price is $0.62.
  • WW International (NASDAQ:WW) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $8.00 price target on the stock. This represents a 1.7% upside from the current price of $7.87.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 American Consumer News, LLC dba MarketBeat.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: The "Scaled Selling Technique" Gives You Exact Profit Targets BEFORE You Enter Any New Trade
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Private investors pour $50 billion into booming sector… investment opportunity

Unstoppable megatrend driven by hundreds of billions in government spending ...